Origin of universal hepatitis B vaccination in Asia

被引:0
|
作者
Mahoney, Richard T. [1 ]
机构
[1] Int Vaccine Inst, Seoul 151600, South Korea
关键词
Economics of hepatitis B vaccine; hepatitis B vaccine; liver cancer; DEVELOPING-COUNTRIES; ANTIGEN; SEROPREVALENCE; IMMUNIZATION; INFECTION; VACCINES; PROGRAM; TAIWAN; VIRUS; SERUM;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic hepatitis B virus infection prevailed inAsian populations, and chronic liver disease and hepatocellular carcinoma were major public health scourges. The prevention of hepatitis B infection by immunization can be seen as one of the great, although unfulfilled, accomplishments of public health. Major reductions in chronic infection in Taiwan, China, Korea and Thailand are the direct result of immunization with hepatitis B vaccine, primarily to newborns and infants. This article reviews the introduction and delivery of hepatitis B vaccine in Asian countries as a result of the efforts of many individuals and organizations beginning in the 1950s and continuing to the present day.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [21] Economic evaluation of universal newborn hepatitis B vaccination in China
    Lu, Sandy Qiuying
    McGhee, Sarah M.
    Xie, Xu
    Cheng, Jinquan
    Fielding, Richard
    VACCINE, 2013, 31 (14) : 1864 - 1869
  • [22] Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain
    Dominguez, Angela
    Avellon, Ana
    Hernando, Victoria
    Soldevila, Nuria
    Borras, Eva
    Martinez, Ana
    Izquierdo, Conchita
    Torner, Nuria
    Pericas, Carles
    Rius, Cristina
    Godoy, Pere
    VACCINES, 2024, 12 (05)
  • [23] Should Europe have a universal hepatitis B vaccination programme?
    Van Damme, Pierre
    Leuridan, Elke
    Hendrickx, Greet
    Vorsters, Alex
    Theeten, Heidi
    Leino, Tuija
    Salminen, Mika
    Kuusi, Markku
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [24] Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992-2005 in China
    Liang, Xiaofeng
    Bi, Shengli
    Yang, Weizhong
    Wang, Longde
    Cui, Gang
    Cui, Fuqiang
    Zhang, Yong
    Liu, Jianhua
    Gong, Xiaohong
    Chen, Yuansheng
    Wang, Fuzhen
    Zheng, Hui
    Wang, Feng
    Guo, Jing
    Jia, Zhiyuan
    Ma, Jingchen
    Wang, Huaqing
    Luo, Huiming
    Li, Li
    Jin, Shuigao
    Hadler, Stephen C.
    Wang, Yu
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (01) : 39 - 47
  • [25] Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
    Akbar, Sheikh Mohammad Fazle
    Al Mahtab, Mamun
    Begum, Ferdousi
    Hossain, Shaikh A. Shahed
    Sarker, Sukumar
    Shrestha, Ananta
    Khan, Md Sakirul Islam
    Yoshida, Osamu
    Hiasa, Yoichi
    VACCINES, 2021, 9 (04)
  • [26] Strategy vaccination against Hepatitis B in China
    Liao, Xueyan
    Liang, Zhenglun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1534 - 1539
  • [27] Neuromuscular disorders associated with Hepatitis B vaccination
    Stuebgen, Joerg-Patrick
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 292 (1-2) : 1 - 4
  • [28] Cancer Prevention by Vaccination Against Hepatitis B
    Chang, Mei-Hwei
    CANCER PREVENTION II, 2009, 181 : 85 - 94
  • [29] The response of hepatitis B vaccination on seronegative adults with different vaccination schedules
    Yao, Jun
    Li, Jing
    Chen, Yongdi
    Shan, Huan
    Dai, Xue-wei
    Yang, Lin-na
    Jiang, Zheng-gang
    Ren, Jing-jing
    Xu, Kai-jin
    Ruan, Bing
    Yang, Shi-gui
    Wang, Bing
    Xie, Tian-sheng
    Li, Qian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (05) : 1102 - 1107
  • [30] Preparing for the next public debate: Universal vaccination against hepatitis B
    Houweling, Hans
    Conyn-van Spaendonck, Marina
    Paulussen, Theo
    Verweij, Marcel
    Ruitenberg, E. Joost
    VACCINE, 2011, 29 (48) : 8960 - 8964